While the S&P 500 may be ending 2016 with double-digits gains, almost a third of the index' individual stocks have gone down. Here are some of the perpetrators you should dump from your portfolio. Abbott Labs  (ABT) shares have lost about 15% of their market value, which means that they're under-performing the S&P 500 by about 25%. Shake Shack (SHAK)  rose 10% on good third-quarter results but the stock has been forming a bearish reversal pattern. Enstar Group's (ESGR) chart is starting to look "toppy" and you should sell it as soon as it hits $190. Alexion Pharmaceuticals (ALXN) has been shedding more than 35% of its market value since January and could go down even more. Bank of New York Mellon (BNY) has rallied 15% since the beginning of the year. The sell signal trigger will happen when it hits $47 a share.

This article was written by a staff member of TheStreet.

More from Video

Biotech and Broadway Come Together to Fight Cancer

Biotech and Broadway Come Together to Fight Cancer

Market Movers: September Grain Stocks Report

Market Movers: September Grain Stocks Report

We Asked Our Pros About the Longevity of the Bull Market

We Asked Our Pros About the Longevity of the Bull Market

Legendary Technician Gives Her View of the Current Market

Legendary Technician Gives Her View of the Current Market

Cannabis: Why It May End Up in Your Portfolio

Cannabis: Why It May End Up in Your Portfolio